Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2+
SponsorNational Cancer Institute (NCI)

About this trial

Selected individuals suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in the tissue bank of the Urologic Oncology Branch. Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI. These materials will be used in the research efforts of the Urologic Oncology Branch, NCI....

Eligibility criteria

Qualifiers

Individuals with biopsy-proven malignant disease

Individuals suspected of having a malignant disease

Individuals who have or are suspected of having an inherited genitourinary malignant disorder

Participants must be >= 2 years of age

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

5,950 Participants
are grouped into 2 trial groups